Combined associations of a polygenic risk score and classical risk factors with breast cancer risk.
- Kapoor, PM
- Mavaddat, N
- Choudhury, PP
- Wilcox, AN
- Lindström, S
- Behrens, S
- Michailidou, K
- Dennis, J
- Bolla, MK
- Wang, Q
- Jung, A
- Abu-Ful, Z
- Ahearn, T
- Andrulis, IL
- Anton-Culver, H
- Arndt, V
- Aronson, KJ
- Auer, PL
- Freeman, LEB
- Becher, H
- Beckmann, MW
- Beeghly-Fadiel, A
- Benitez, J
- Bernstein, L
- Bojesen, SE
- Brauch, H
- Brenner, H
- Brüning, T
- Cai, Q
- Campa, D
- Canzian, F
- Carracedo, A
- Carter, BD
- Castelao, JE
- Chanock, SJ
- Chatterjee, N
- Chenevix-Trench, G
- Clarke, CL
- Couch, FJ
- Cox, A
- Cross, SS
- Czene, K
- Dai, JY
- Earp, HS
- Ekici, AB
- Eliassen, AH
- Eriksson, M
- Evans, DG
- Fasching, PA
- Figueroa, J
- Fritschi, L
- Gabrielson, M
- Gago-Dominguez, M
- Gao, C
- Gapstur, SM
- Gaudet, MM
- Giles, GG
- González-Neira, A
- Guénel, P
- Haeberle, L
- Haiman, CA
- Håkansson, N
- Hall, P
- Hamann, U
- Hatse, S
- Heyworth, J
- Holleczek, B
- Hoover, RN
- Hopper, JL
- Howell, A
- Hunter, DJ
- ABCTB Investigators
- kConFab/AOCS Investigators
- John, EM
- Jones, ME
- Kaaks, R
- Keeman, R
- Kitahara, CM
- Ko, Y-D
- Koutros, S
- Kurian, AW
- Lambrechts, D
- Marchand, LL
- Lee, E
- Lejbkowicz, F
- Linet, M
- Lissowska, J
- Llaneza, A
- MacInnis, RJ
- Martinez, ME
- Maurer, T
- McLean, C
- Neuhausen, SL
- Newman, WG
- Norman, A
- O'Brien, KM
- Olshan, AF
- Olson, JE
- Olsson, H
- Orr, N
- Perou, CM
- Pita, G
- Polley, EC
- Prentice, RL
- Rennert, G
- Rennert, HS
- Ruddy, KJ
- Sandler, DP
- Saunders, C
- Schoemaker, MJ
- Schöttker, B
- Schumacher, F
- Scott, C
- Scott, RJ
- Shu, X-O
- Smeets, A
- Southey, MC
- Spinelli, JJ
- Stone, J
- Swerdlow, AJ
- Tamimi, RM
- Taylor, JA
- Troester, MA
- Vachon, CM
- van Veen, EM
- Wang, X
- Weinberg, CR
- Weltens, C
- Willett, W
- Winham, SJ
- Wolk, A
- Yang, XR
- Zheng, W
- Ziogas, A
- Dunning, AM
- Pharoah, PDP
- Schmidt, MK
- Kraft, P
- Easton, DF
- Milne, RL
- García-Closas, M
- Chang-Claude, J
DOIAbstract
We evaluated the joint associations between a new 313-variant PRS (PRS313) and questionnaire-based breast cancer risk factors for women of European ancestry, using 72,284 cases and 80,354 controls from the Breast Cancer Association Consortium. Interactions were evaluated using standard logistic regression, and a newly developed case-only method, for breast cancer risk overall and by estrogen receptor status. After accounting for multiple testing, we did not find evidence that per-standard deviation PRS313 odds ratio differed across strata defined by individual risk factors. Goodness-of-fit tests did not reject the assumption of a multiplicative model between PRS313 and each risk factor. Variation in projected absolute lifetime risk of breas...
Add to ORKG